Manulife (Manufacturers Life Insurance)
VYGR icon

Manulife (Manufacturers Life Insurance)’s Voyager Therapeutics VYGR Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.8K Buy
17,382
+4,024
+30% +$15.3K ﹤0.01% 2829
2026
Q1 		$51.6K Sell
13,358
-78,388
-85% -$309K ﹤0.01% 2734
2025
Q4 		$361K Sell
91,746
-2,444
-3% -$10.8K ﹤0.01% 2300
2025
Q3 		$440K Sell
94,190
-1,221
-1% -$4.42K ﹤0.01% 2261
2025
Q2 		$297K Buy
95,411
+2,188
+2% +$7.06K ﹤0.01% 2394
2025
Q1 		$315K Sell
93,223
-84
-0.1% -$392 ﹤0.01% 2322
2024
Q4 		$529K Sell
93,307
-588
-0.6% -$3.79K ﹤0.01% 2209
2024
Q3 		$549K Sell
93,895
-503
-0.5% -$3.66K ﹤0.01% 2243
2024
Q2 		$747K Buy
94,398
+5,365
+6% +$45K ﹤0.01% 2009
2024
Q1 		$829K Buy
89,033
+10,757
+14% +$90.8K ﹤0.01% 1953
2023
Q4 		$661K Hold
78,276
– – ﹤0.01% 2040
2023
Q3 		$607K Hold
78,276
– – ﹤0.01% 2036
2023
Q2 		$896K Buy
78,276
+1,269
+2% +$13.1K ﹤0.01% 1717
2023
Q1 		$594K Hold
77,007
– – ﹤0.01% 1906
2022
Q4 		$436K Sell
77,007
-429
-0.6% -$2.44K ﹤0.01% 2081
2022
Q3 		$465K Hold
77,436
– – ﹤0.01% 2029
2022
Q2 		$460K Buy
+77,436
New +$523K ﹤0.01% 2110
2021
Q1 		– Sell
-17,514
Closed -$125K – 3128
2020
Q4 		$125K Buy
17,514
+1,395
+9% +$13.4K ﹤0.01% 2915
2020
Q3 		$172K Hold
16,119
– – ﹤0.01% 2633
2020
Q2 		$197K Sell
16,119
-50
-0.3% -$582 ﹤0.01% 2512
2020
Q1 		$148K Buy
16,169
+1,010
+7% +$11.6K ﹤0.01% 2452
2019
Q4 		$211K Sell
15,159
-292
-2% -$4.24K ﹤0.01% 2563
2019
Q3 		$264K Hold
15,451
– – ﹤0.01% 2406
2019
Q2 		$421K Buy
+15,451
New +$354K ﹤0.01% 2149
2018
Q3 		– Sell
-16,725
Closed -$327K – 3867
2018
Q2 		$327K Buy
16,725
+3,368
+25% +$66.6K ﹤0.01% 2714
2018
Q1 		$251K Sell
13,357
-710
-5% -$15.3K ﹤0.01% 2845
2017
Q4 		$233K Buy
14,067
+1,068
+8% +$18.3K ﹤0.01% 2887
2017
Q3 		$268K Buy
12,999
+12,253
+1,642% +$138K ﹤0.01% 2745
2017
Q2 		$7K Sell
746
-9,860
-93% -$99.2K ﹤0.01% 3869
2017
Q1 		$140K Buy
10,606
+1,175
+12% +$14.3K ﹤0.01% 3034
2016
Q4 		$120K Buy
9,431
+56
+0.6% +$719 ﹤0.01% 3145
2016
Q3 		$113K Hold
9,375
– – ﹤0.01% 3159
2016
Q2 		$103K Buy
9,375
+6,508
+227% +$79.6K ﹤0.01% 3203
2016
Q1 		$25K Buy
+2,867
New +$32.5K ﹤0.01% 3440

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s VYGR Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Voyager Therapeutics (VYGR) stake by 30% in Q2 2026, buying an estimated $15.3K and bringing the position to 17,382 shares worth $60.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2829.

Manulife (Manufacturers Life Insurance) first reported a position in VYGR in Q1 2016 and has held it in 34 quarters since. The position peaked at $896K in Q2 2023. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 17,382 shares of Voyager Therapeutics worth $60.8K as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) bought 4,024 Voyager Therapeutics shares in Q2 2026, an estimated $15.3K.
  • Voyager Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #2829 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Voyager Therapeutics in Q1 2016 and has held it in 34 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Voyager Therapeutics position peaked at $896K in Q2 2023.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.